Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Yang, Min Hui ^a   Yu, Jiang ^a   Chen, Na ^a   Wang, Xiao Yan ^a   Liu, Xiang Yu ^b   Wang, Shuang ^a   Ding, Yan Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; MATRIX ATTACHMENT REGION BINDING PROTEIN; MICRORNA; MIRN31 MICRORNA, HUMAN; RNA; SATB2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ADULT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COLORECTAL TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR INVASION;

3' UNTRANSLATED REGIONS; ADULT; ANIMALS; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, NEOPLASM; TRANSCRIPTION FACTORS;

EID: 84893631835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085353     Document Type: Article

References (44)

1. Weitz J, Koch M, Debus J, Höhler T, Galle PR et al. (2005) Colorectal cancer. Lancet 365: 153-165. doi:10.1016/S0140-6736(05)17706-X. PubMed: 15639298. (Pubitemid 40091806)
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. doi:10.1016/S0092-8674(04)00045-5. PubMed: 14744438.
3. Croce CM, Calin GA (2005) miRNAs, cancer, and stem cell division. Cell 122: 6-7. doi:10.1016/j.cell.2005.06.036. PubMed: 16009126. (Pubitemid 40977933)
4. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86. doi:10.1126/science. 1091903. PubMed: 14657504. (Pubitemid 38055775)
5. Stahlhut Espinosa CE, Slack FJ (2006) The role of microRNAs in cancer. Yale J Biol Med 79: 131-140. PubMed: 17940623.
6. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591. doi:10.1016/j.cell.2009.02.005. PubMed: 19239879.
7. Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K et al. (2012) MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PLOS ONE 7: e29671. doi:10.1371/journal.pone.0029671. PubMed: 22295063.
8. Tchernitsa O, Kasajima A, Schäfer R, Kuban RJ, Ungethüm U et al. (2010) Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 222: 310-319. doi:10.1002/path.2759. PubMed: 20726036.
9. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261. doi:10.1073/pnas.0510565103. PubMed: 16461460. (Pubitemid 43271657)
10. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B et al. (2009) Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26: 27-34. doi:10.1155/2009/921907. PubMed: 19242066.
11. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29. doi:10.1186/1476-4598-5-29. PubMed: 16854228.
12. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402. doi:10.1159/000113489. PubMed: 18196926. (Pubitemid 351238155)
13. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592. doi:10.1158/1078-0432.CCR-07-0666. PubMed: 18451220.
14. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046. doi:10.1016/j.cell. 2009.03.047. PubMed: 19524507.
15. Guo J, Miao Y, Xiao B, Huan R, Jiang Z et al. (2009) Differential expression of microRNA species in human gastric cancer versus nontumorous tissues. J Gastroenterol Hepatol 24: 652-657. doi:10.1111/j. 1440-1746.2008.05666.x. PubMed: 19175831.
16. Ivanov SV, Goparaju CM, Lopez P, Zavadil J, Toren-Haritan G et al. (2010) Pro-tumorigenic effects of miR-31 loss in mesothelioma. J Biol Chem 285: 22809-22817. doi:10.1074/jbc.M110.100354. PubMed: 20463022.
17. Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM et al. (2013) Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas 42: 67-71. doi:10.1097/MPA.0b013e3182592ba7. PubMed: 22850622.
18. Zhang YF, Liu L, Ding YQ (2007) Isolation and characterization of human colorectal cancer cell subline with unique metastatic potential in the liver. NAN Fang Yi Ke da Xue Xue Bao 27: 126-130. PubMed: 17355917.
19. Wang S, Zhou J, Wang XY, Hao JM, Chen JZ et al. (2009) Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol 219: 114-122. doi:10.1002/path.2575. PubMed: 19557828.
20. Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ et al. (2010) A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. J Pathol 220: 475-489. PubMed: 20077526.
21. Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW et al. (2011) Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer 117: 3193-3200. doi:10.1002/cncr.25907. PubMed: 21264844.
22. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M et al. (2004) Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 10: 8465-8471. doi:10.1158/1078-0432. CCR-04-0653. PubMed: 15623626. (Pubitemid 40053411)
23. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK et al. (2004) Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279: 25813-25822. doi:10.1074/jbc.M313538200. PubMed: 15073169.
24. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319. doi:10.1038/nprot.2006.339. PubMed: 17406473.
25. Mitamura T, Watari H, Wang L, Kanno H, Hassan MK et al. (2013) Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogenesis 2: e40. doi:10.1038/oncsis.2013.3. PubMed: 23552883.
26. Körner C, Keklikoglou I, Bender C, Wörner A, Münstermann E et al. (2013) MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J Biol Chem 288: 8750-8761. doi:10.1074/jbc.M112.414128. PubMed: 23364795.
27. Sun D, Yu F, Ma Y, Zhao R, Chen X et al. (2013) MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem 288: 9508-9518. doi:10.1074/jbc.M112.367763. PubMed: 23322774.
28. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K et al. (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13: 1668-1674. doi:10.1261/rna.642907. PubMed: 17698639. (Pubitemid 47481675)
29. Hu Y, Correa AM, Hoque A, Guan B, Ye F et al. (2011) Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128: 132-143. doi:10.1002/ijc.25330. PubMed: 20309880.
30. Aprelikova O, Yu X, Palla J, Wei BR, John S et al. (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 9: 4387-4398. doi:10.4161/cc.9.21.13674. PubMed: 20980827.
31. Wang S, Li Q, Wang K, Dai Y, Yang J et al. (2013) Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. Clin Transl Oncol 15: 849-854. doi:10.1007/s12094-013-1014-4. PubMed: 23408039.
32. Tan X, Qin W, Zhang L, Hang J, Li B et al. (2011) A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res 17: 6802-6811. doi:10.1158/1078-0432.CCR-11-0419. PubMed: 21890451.
33. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120: 1298-1309. doi:10.1172/JCI39566. PubMed: 20237410.
34. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355. doi:10.1038/nature02871. PubMed: 15372042.
35. Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P et al. (2013) Prognostic implications of serum microRNA-21 in colorectal cancer. J Surg Oncol 108: 369-373. doi:10.1002/jso.23415. PubMed: 23970420.
36. Schee K, Lorenz S, Worren MM, Gunther CC, Holden M et al. (2013) Deep Sequencing the MicroRNA Transcriptome in Colorectal. Cancer - PLOS ONE 8: e66165. doi:10.1371/journal.pone.0066165.
37. Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM et al. (2013) Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma. PLOS ONE 8: e73009. doi:10.1371/journal.pone.0073009. PubMed: 24039846.
38. Bera A, Ghosh-Choudhury N, Dey N, Das F, Kasinath BS et al. (2013) NFkappaB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell Signal 25: 2575-2586. doi:10.1016/j.cellsig.2013.08. 005. PubMed: 23981302.
39. Saxena A, Shoeb M, Ramana KV, Srivastava SK (2013) Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4). Expression - Eur J Cancer 49: 3311-3319. doi:10.1016/j.ejca. 2013.05.031.
40. Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336. doi:10.1074/jbc. M611393200. PubMed: 17363372. (Pubitemid 47100416)
41. Ma X, Choudhury SN, Hua X, Dai Z, Li Y (2013) Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway. Carcinogenesis 34: 1216-1223. doi:10.1093/carcin/bgt044. PubMed: 23385064.
42. Dobreva G, Dambacher J, Grosschedl R (2003) SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17: 3048-3061. doi:10.1101/gad. 1153003. PubMed: 14701874.
43. Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B et al. (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125: 971-986. doi:10.1016/j.cell. 2006.05.012. PubMed: 16751105.
44. Gyorgy AB, Szemes M, de Juan Romero C, Tarabykin V, Agoston DV (2008) SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. Eur J Neurosci 27: 865-873. doi: 10.1111/j.1460-9568.2008.06061.x. PubMed: 18333962. (Pubitemid 351365172)